Inactive Instrument

Calmare Therapeutics Incorporated

CTTC

US13126R1023

Advanced Medical Equipment & Technology

Calmare Therapeutics Incorporated Wins $15 Million General Supply Order Contract

February 18, 2016 at 06:15 pm EST

Calmare Therapeutics Incorporated has been issued a general supply order contract - GSA contract #V797P-4300B (the "Contract") for an estimated total of $15 million over the next 60 months.

Latest news about Calmare Therapeutics Incorporated

Calmare Therapeutics Incorporated Wins $2.5 Million Federal Supply Schedule Contract	20-06-09	CI
Calmare Therapeutics Incorporated Announces Board Changes	19-07-19	CI
Carl O'connell to Resign as Member of the Board of Directors of Calmare Therapeutics Incorporation, Effective on or About June 26, 2019	19-06-12	CI
Declaration of Voting Results by Calmare Therapeutics	18-07-02	CI
Calmare Therapeutics Declares Preliminary Tally of Consents by Shareholders	18-06-15	CI
Calmare Therapeutics Solicits Proxies from Shareholders	18-01-16	CI
Calmare Therapeutics Solicits Proxies from Shareholders	18-01-12	CI
Calmare Therapeutics Solicits Proxies from Shareholders	18-01-02	CI
Stanley Yarbro Solicits Proxies from Shareholders of Calmare Therapeutics	17-12-08	CI
Stanley Yarbro Solicits Proxies from Shareholders of Calmare Therapeutics	17-12-04	CI
Stanley Yarbro Solicits Proxies from Shareholders of Calmare Therapeutics	17-11-22	CI
Stanley Yarbro Sends Letter to Board of Directors of Calmare Therapeutics	17-09-21	CI
Stanley Yarbro Sends Director Nomination Notice to Calmare Therapeutics	17-09-21	CI
Stanley Yarbro Threatens Calmare Therapeutics with Legal Action	17-09-21	CI
Calmare Therapeutics Incorporated Auditor Raises 'Going Concern' Doubt	17-07-20	CI
Stanley Yarbro Sends Letter to Calmare Therapeutics	17-06-30	CI
Calmare Therapeutics, Inc. Removes Stan Yarbro as Director	17-03-23	CI
Calmare Therapeutics Incorporated Resignation of Robert T. Conway and Steve Roehrich from the Board	17-02-23	CI
Calmare Therapeutics Incorporated cancelled the transaction announced on September 10, 2013	16-09-09	CI
Calmare Therapeutics Incorporated Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2016	16-05-19	CI
Calmare Therapeutics Incorporated Receives Final Signatures on Supply Order Contract Documents	16-05-05	CI
Calmare Therapeutics Incorporated Auditor Raises 'Going Concern' Doubt	16-04-13	CI
Calmare Therapeutics Incorporated Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015	16-03-02	CI
Calmare Therapeutics Incorporated Wins $15 Million General Supply Order Contract	16-02-18	CI
Calmare Therapeutics Incorporated Appoints Christine Chansky, M.D., J.D., F.C.L.M., as a Chief Regulatory Officer	16-02-17	CI

Chart Calmare Therapeutics Incorporated

Duration

Period

More charts

Calmare Therapeutics Incorporated is a biotherapeutic company. The Company's medical devices offer a non-pharmacological (no drugs), non-addictive (no narcotics) and non-invasive (over the skin) solution to chronic pain sufferers in an outpatient treatment setting. It supplements its medical devices with a catalog of private label neurostimulation and sensory electrodes. Its flagship medical device, the Calmare Pain Therapy Device is a non-invasive and non-addictive modality that treats chronic and neuropathic pain. Its devices are commercially sold to medical practices throughout the world. Its technology portfolio includes PMT 1, Neuroprotection and Cognitive Enhancement, Sexual Dysfunction Therapeutic, Skin Pigment Enhancer and Wound Sealant. The Company's clients include universities, corporations, and inventors.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+12.15%	227B
DANAHER CORPORATION	+14.90%	197B
INTUITIVE SURGICAL, INC.	+18.22%	141B
BOSTON SCIENTIFIC CORPORATION	+29.15%	110B
SIEMENS HEALTHINEERS AG	+0.53%	64.15B
EDWARDS LIFESCIENCES CORPORATION	+16.92%	53.72B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+6.33%	51.75B
AGILENT TECHNOLOGIES, INC.	+10.93%	45.2B
GE HEALTHCARE TECHNOLOGIES INC.	+5.87%	37.37B

Other Advanced Medical Equipment & Technology